Latest SUVRETTA CAPITAL MANAGEMENT, LLC Stock Portfolio

SUVRETTA CAPITAL MANAGEMENT, LLC Performance:

2025 Q1: -3.62%YTD: -3.62%2024: 14.83%

Performance for 2025 Q1 is -3.62%, and YTD is -3.62%, and 2024 is 14.83%.

About SUVRETTA CAPITAL MANAGEMENT, LLC and 13F Hedge Fund Stock Holdings

SUVRETTA CAPITAL MANAGEMENT, LLC is a hedge fund based in NEW YORK, NY. On 14-Jun-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $5.2 Billions. In it's latest 13F Holdings report, SUVRETTA CAPITAL MANAGEMENT, LLC reported an equity portfolio of $2.7 Billions as of 31 Mar, 2025.

The top stock holdings of SUVRETTA CAPITAL MANAGEMENT, LLC are ARQT, , BNTC. The fund has invested 6.6% of it's portfolio in ARCUTIS BIOTHERAPEUTICS INC and 5% of portfolio in BIOHAVEN LTD.

The fund managers got completely rid off STARBUCKS CORP (SBUX), MCDONALDS CORP (MCD) and VERIZON COMMUNICATIONS INC (VZ) stocks. They significantly reduced their stock positions in CRH PLC (CRH), GOLDMAN SACHS GROUP INC (GS) and COCA COLA CO (KO). SUVRETTA CAPITAL MANAGEMENT, LLC opened new stock positions in HOME DEPOT INC (HD), BANK AMERICA CORP (BAC) and CHIPOTLE MEXICAN GRILL INC (CMG). The fund showed a lot of confidence in some stocks as they added substantially to ARCUS BIOSCIENCES INC (RCUS), MERCK & CO INC (MRK) and APELLIS PHARMACEUTICALS INC (APLS).

SUVRETTA CAPITAL MANAGEMENT, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that SUVRETTA CAPITAL MANAGEMENT, LLC made a return of -3.62% in the last quarter. In trailing 12 months, it's portfolio return was -0.51%.

New Buys

Ticker	$ Bought
home depot inc	35,758,800
bank america corp	31,460,800
chipotle mexican grill inc	27,090,300
mineralys therapeutics inc	26,484,000
snowflake inc	20,153,400
aura biosciences inc	16,008,900
take-two interactive softwar	15,004,900
moderna inc	14,661,600

New stocks bought by SUVRETTA CAPITAL MANAGEMENT, LLC

Additions

Ticker	% Inc.
arcus biosciences inc	344
merck & co inc	171
apellis pharmaceuticals inc	107
nvidia corporation	95.16
united airls hldgs inc	82.59
immatics n.v	80.35
ultragenyx pharmaceutical in	75.84
abbott labs	75.48

Additions to existing portfolio by SUVRETTA CAPITAL MANAGEMENT, LLC

Reductions

Ticker	% Reduced
crh plc	-96.78
goldman sachs group inc	-65.58
coca cola co	-63.46
unitedhealth group inc	-60.24
intra-cellular therapies inc	-51.29
ferguson enterprises inc	-47.08
sanofi	-36.35
boston scientific corp	-34.09

SUVRETTA CAPITAL MANAGEMENT, LLC reduced stake in above stock

Sold off

Ticker	$ Sold
scpharmaceuticals inc	-6,516,750
verizon communications inc	-29,529,200
starbucks corp	-46,986,600
boeing co	-27,469,900
mcdonalds corp	-30,043,600
disney walt co	-10,531,500
ge healthcare technologies i	-5,863,500
dominos pizza inc	-16,093,600

SUVRETTA CAPITAL MANAGEMENT, LLC got rid off the above stocks

Sector Distribution

SUVRETTA CAPITAL MANAGEMENT, LLC has about 47.3% of it's holdings in Healthcare sector.

Sector	%
Healthcare	47.3
Others	23.5
Technology	9.1
Consumer Cyclical	7.2
Communication Services	5.3
Financial Services	3.6
Industrials	2.6
Consumer Defensive	1.2

Market Cap. Distribution

SUVRETTA CAPITAL MANAGEMENT, LLC has about 38.9% of it's portfolio invested in the large-cap and mega-cap stocks.

Category	%
UNALLOCATED	23.4
MEGA-CAP	21.4
SMALL-CAP	21.1
LARGE-CAP	17.5
MID-CAP	9.2
MICRO-CAP	6.9

Stocks belong to which Index?

About 62.6% of the stocks held by SUVRETTA CAPITAL MANAGEMENT, LLC either belong to S&P 500 or RUSSELL 2000 index.

Index	%
Others	37.4
S&P 500	32.4
RUSSELL 2000	30.2

Top 5 Winners (%)		%
ITCI	intra-cellular therapies inc	55.7 %
TRVI	trevi therapeutics inc	47.0 %
KALV	kalvista pharmaceuticals inc	36.3 %
GE	ge aerospace	20.0 %
MCK	mckesson corp	18.1 %

Top 5 Winners ($)		$
ITCI	intra-cellular therapies inc	66.9 M
ARQT	arcutis biotherapeutics inc	19.5 M
KALV	kalvista pharmaceuticals inc	15.1 M
INSM	insmed inc	11.9 M
KO	coca cola co	8.7 M

Top 5 Losers (%)		%
STRO	sutro biopharma inc	-64.6 %
PEPG	pepgen inc	-56.1 %
PROK	prokidney corp	-48.1 %
SRPT	sarepta therapeutics inc	-47.5 %
ERAS	erasca inc	-45.4 %

Top 5 Losers ($)		$
TSLA	tesla inc	-20.4 M
RCKT	rocket pharmaceuticals inc	-18.5 M
ERAS	erasca inc	-14.0 M
EYPT	eyepoint pharmaceuticals inc	-13.8 M
KURA	kura oncology inc	-13.3 M

SUVRETTA CAPITAL MANAGEMENT, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of SUVRETTA CAPITAL MANAGEMENT, LLC

SUVRETTA CAPITAL MANAGEMENT, LLC has 99 stocks in it's portfolio. About 41.7% of the portfolio is in top 10 stocks. TSLA proved to be the most loss making stock for the portfolio. ITCI was the most profitable stock for SUVRETTA CAPITAL MANAGEMENT, LLC last quarter.

Last Reported on: 15 May, 2025

Ticker	Namesorted ascending	% Portfolio	Shares Held	$ Value	Type	% Change
A	agilent technologies inc	0.02	4,990	583,730	unchanged	0.00

AADI	whitehawk therapeutics inc	0.24	3,700,000	6,586,000	new

ABC	cencora inc	0.13	12,488	3,472,790	unchanged	0.00

ABEO	abeona therapeutics inc	0.65	3,685,500	17,543,000	unchanged	0.00

ABT	abbott labs	0.29	58,820	7,802,470	added	75.48

ALGN	align technology inc	0.00	0.00	0.00	sold off	-100

ALNY	alnylam pharmaceuticals inc	0.09	9,370	2,530,090	new

AMD	advanced micro devices inc	1.54	404,008	41,507,800	added	19.74

AMZN	amazon com inc	2.50	354,356	67,419,800	added	0.88

APLS	apellis pharmaceuticals inc	1.34	1,646,620	36,011,500	added	107

ARQT	arcutis biotherapeutics inc	6.63	11,423,000	178,655,000	added	0.21

AURA	aura biosciences inc	0.59	2,731,890	16,008,900	new

AVTR	avantor inc	0.04	71,850	1,164,690	unchanged	0.00

BA	boeing co	0.00	0.00	0.00	sold off	-100

BAC	bank america corp	1.17	753,913	31,460,800	new

BAX	baxter intl inc	0.01	7,970	272,813	unchanged	0.00

BIIB	biogen inc	0.61	120,736	16,521,500	added	4.59

BMY	bristol-myers squibb co	0.00	0.00	0.00	sold off	-100

BNTC	benitec biopharma inc	4.77	9,876,510	128,493,000	added	10.23

BSX	boston scientific corp	0.98	262,099	26,440,500	reduced	-34.09